Loading
NASDAQHealthcareMedical - Specialties
Latest quote
$0.4961
−$0.0469 · -8.64%
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Regular session
$0.4961
−$0.0469 · -8.64%
Regular session · ET · Market data may be delayed.
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Day range
Current $0.4961
52-week range
Current $0.4961
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
25
Expensive
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Day range
Current $0.4961
52-week range
Current $0.4961
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development | 13.45M USD | 11.05M USD | 6.8M USD | 5.68M USD | 255K USD |
| Selling, general, and administrative | 7.69M USD | 8.84M USD | 8.52M USD | 7.35M USD | 2.03M USD |
| Operating expenses | 21.14M USD | 19.89M USD | 15.31M USD | 13.03M USD | 2.29M USD |
| Interest income | 122K USD | 446K USD | 675K USD | 66K USD | 2.17K USD |
| Interest expense | — | — | — | 66K USD | 2.17M USD |
| Depreciation and amortization | 40K USD | 7K USD | 15.31M USD | 13.03M USD | — |
| Operating income | −21.14M USD | −19.89M USD | −15.31M USD | −13.03M USD | −2.29M USD |
| Net income | −21.02M USD | −19.45M USD | −14.64M USD | −12.96M USD | −4.43M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$2.00
303.14% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
iShares Micro-Cap ETFIWCAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
